CHP
XFOR icon

Cable Hill Partners’s X4 Pharmaceuticals XFOR Stock Holding History

Cable Hill Partners’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9
Closed -$5K – 715
2019
Q1 		$5K Buy
9
+8
+800% +$4.42K ﹤0.01% 632
2018
Q4 		$0 Sell
1
-55
-98% -$21K ﹤0.01% 848
2018
Q3 		$17K Buy
56
+45
+409% +$19.1K 0.01% 340
2018
Q2 		$7K Buy
11
+5
+83% +$16.4K ﹤0.01% 575
2018
Q1 		$22K Buy
+6
New +$17.5K 0.01% 329

Other funds holding XFOR

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Cable Hill Partners's XFOR Position: Q2 2019 in Review

Cable Hill Partners sold out of X4 Pharmaceuticals (XFOR) in Q2 2019, closing a stake of 9 shares — an estimated $5K sold.

Cable Hill Partners first reported a position in XFOR in Q1 2018 and held it in 5 quarters. The position peaked at $22K in Q1 2018. 43 funds tracked by Wall St. Rank hold XFOR as of Q2 2019.

  • Cable Hill Partners reported no remaining X4 Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 9 X4 Pharmaceuticals shares in Q2 2019, an estimated $5K.
  • Cable Hill Partners first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 5 quarters.
  • Cable Hill Partners's X4 Pharmaceuticals position peaked at $22K in Q1 2018.
  • 43 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.